RICHARD T HUME, a director at $SNX, sold 356 shares of the company on 01-05-2026 for an estimated $55,685. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.7% of their shares of this class of stock. Following this trade, they now own 47,515 shares of this class of $SNX stock.
$SNX Insider Trading Activity
$SNX insiders have traded $SNX stock on the open market 52 times in the past 6 months. Of those trades, 0 have been purchases and 52 have been sales.
Here’s a breakdown of recent trading of $SNX stock by insiders over the last 6 months:
- DENNIS POLK (Hyve Solutions Executive) has made 0 purchases and 23 sales selling 35,353 shares for an estimated $5,443,622.
- RICHARD T HUME has made 0 purchases and 13 sales selling 20,000 shares for an estimated $3,077,978.
- ALIM DHANJI (Chief Human Resources Officer) has made 0 purchases and 7 sales selling 3,019 shares for an estimated $451,331.
- MARSHALL WITT (Chief Financial Officer) has made 0 purchases and 3 sales selling 2,584 shares for an estimated $382,197.
- MIRIAM ANNE MURPHY (President, Europe) has made 0 purchases and 2 sales selling 1,673 shares for an estimated $261,810.
- ANN F VEZINA sold 812 shares for an estimated $122,141
- REYNA THOMPSON (President, North America) sold 521 shares for an estimated $81,265
- MERLINE SAINTIL has made 0 purchases and 2 sales selling 504 shares for an estimated $78,113.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SNX Hedge Fund Activity
We have seen 242 institutional investors add shares of $SNX stock to their portfolio, and 201 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,800,437 shares (-21.7%) from their portfolio in Q3 2025, for an estimated $294,821,558
- NINETY ONE UK LTD removed 979,248 shares (-33.2%) from their portfolio in Q3 2025, for an estimated $160,351,860
- THRIVENT FINANCIAL FOR LUTHERANS added 961,696 shares (+3094.0%) to their portfolio in Q3 2025, for an estimated $157,477,720
- ALYESKA INVESTMENT GROUP, L.P. added 828,280 shares (+inf%) to their portfolio in Q3 2025, for an estimated $135,630,850
- BRAVE WARRIOR ADVISORS, LLC removed 493,258 shares (-13.1%) from their portfolio in Q3 2025, for an estimated $80,770,997
- VICTORY CAPITAL MANAGEMENT INC added 402,573 shares (+123.6%) to their portfolio in Q3 2025, for an estimated $65,921,328
- MARSHALL WACE, LLP added 396,766 shares (+6626.0%) to their portfolio in Q3 2025, for an estimated $64,970,432
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SNX Revenue
$SNX had revenues of $15.7B in Q3 2025. This is an increase of 6.58% from the same period in the prior year.
You can track SNX financials on Quiver Quantitative's SNX stock page.
$SNX Analyst Ratings
Wall Street analysts have issued reports on $SNX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 09/29/2025
- UBS issued a "Buy" rating on 09/29/2025
- B of A Securities issued a "Buy" rating on 09/26/2025
- RBC Capital issued a "Outperform" rating on 09/26/2025
- Morgan Stanley issued a "Overweight" rating on 09/26/2025
To track analyst ratings and price targets for $SNX, check out Quiver Quantitative's $SNX forecast page.
$SNX Price Targets
Multiple analysts have issued price targets for $SNX recently. We have seen 8 analysts offer price targets for $SNX in the last 6 months, with a median target of $178.5.
Here are some recent targets:
- Erik Woodring from Morgan Stanley set a target price of $177.0 on 12/17/2025
- David Vogt from UBS set a target price of $187.0 on 09/29/2025
- Vincent Colicchio from Barrington Research set a target price of $182.0 on 09/29/2025
- Tim Long from Barclays set a target price of $164.0 on 09/26/2025
- Ruplu Bhattacharya from B of A Securities set a target price of $180.0 on 09/26/2025
- Ashish Sabadra from RBC Capital set a target price of $180.0 on 09/26/2025
- Michael Ng from Goldman Sachs set a target price of $164.0 on 09/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
